Gary Pestano, Ph.D. is a development leader in assays and products of high complexity molecular diagnostics in oncology and virology, including genomic and proteomic technologies. In addition to serving as the Chief Scientific Officer and the head of R&D at Biodesix, Gary is the NYS Laboratory Director of the company’s CLEP | CLIA | ISO13485-certified laboratory in Colorado.
Prior to joining Biodesix in 2012, Dr. Pestano led multidisciplinary teams in the development of multiplexed tissue and cell-based diagnostic assays, cancer vaccines and scientific modeling software. He held senior positions in Discovery, Development, Pharma Services, and global Project Leadership at Ventana, a member of the Roche Group.
Dr. Pestano is the co-inventor on multiple national and international patents including for novel devices and detection systems for nucleic acid, cell, and tissue diagnostics. He has also fostered many collaborations at leading academic centers, academic/industry consortia, and in the biotechnology industry as a part of both R&D and new product development.
Dr. Pestano received his Ph.D. training in Cell and Molecular Biology at The Graduate Center, City University of New York and conducted his post-doctoral training in cancer immunology at the Dana Farber Cancer Institute and Harvard Medical School. Dr. Pestano holds advanced training certificates from Harvard Business School, MIT, and the University of London.
Gary Pestano, Ph.D.
Posted
in
by
Tags: